| News

Redesigning Healthcare - Das war die Future Health 2019

05.02.2019

In der Gesundheitslandschaft der Zukunft steht der Patient im Mittelpunkt. Das zeigte auch die Future Health 2019 in Basel, die Ende Januar 350 Gäste anzog. Unter dem Titel “Redesigning Healthcare” diskutierten über 20 Referentinnen und Referenten über das Gesundheitssystem der Zukunft.

Noch werde der Patient zu wenig einbezogen, sagte Stephan Sigrist vom Think Tank W.I.R.E. Viele Patientinnen und Patienten wünschten sich mehr Transparenz, Partizipation und Dialog bei der Behandlung und insgesamt eine individuellere Betreuung.

Eine weitere Herausforderung beim Umbau des Gesundheitssystems sind Probleme, die sich aus der Nutzung biomedizinischer Daten ergeben. Effy Vayena, Professorin an der Universität Zürich, erforscht die Ethik der personalisierten Medizin. Sie widmete sich in ihrer Keynote der Frage, wer Gesundheitsdaten sammeln und auswerten dürfe.

Start-ups des DayOne Accelerators an der Future Health

Dass es an Ideen für die Zukunft der Gesundheitsindustrie nicht mangelt, bewiesen die Start-ups, die an der Future Health ihre Geschäftsmodelle präsentierten: Das Start-up Advancience aus Basel ermöglicht es, psychische Erkrankungen und auch bereits erste Anzeichen dafür mit Hilfe einer Software zu diagnostizieren. Beim Spielen eines Videogames werden verschiedene Parameter der Gehirnfunktion gemessen. Der Patient müsse für die Messung keine persönlichen Daten preisgeben, erklärte CEO und Co-Founder Christian Vogler in seinem Pitch. Advancience entstand an der Universität Basel. Das Start-up gehört ausserdem zu den Finalisten des DayOne Accelerators.

Auch das DayOne Accelerator Start-up Noul präsentierte seine Lösung für ein grosses Problem: «Jedes Jahr sterben weltweit 450’000 Menschen an Malaria – 70 Prozent davon sind Kinder», sagte Chang Rok Yun, Director of Global Development bei Noul, an der FutureHealth Basel. Um die vor allem in Entwicklungsländern verbreitete Krankheit effektiver zu bekämpfen, hat Noul ein tragbares Gerät namens MiLab entwickelt, dass ohne Labor und Techniker und nur anhand einer Blutprobe selbständig Malaria diagnostizieren kann. In Zukunft soll MiLab auch weitere Infektionskrankheiten erkennen, so Chang.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
Basel Area Business & Innovation, Innovation

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.